Ski great to retire aged 27 after Crohn's diagnosis
Jarl Magnus Riiber, the most successful Nordic combined athlete of all time, will retire at the end of the season aged 27 ...
Too Old to Operate6h
Mediterranean Diet’s Impact on Crohn’s Disease Management
The following is a summary of “Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort,” published in the ...
Science Daily1d
Crohn's Disease News
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...
The American Journal of Managed Care5d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
‘Too good to be true’: Free Blue Circle program seeks to transform Type 1 diabetes care in Ohio
Blue Circle Health can provide free services in Ohio and selected other states thanks to support from the Leona M. and Harry ...
Ibj.com1d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Jewish Press1d
Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Crohn’s Disease Pipeline Insights, FDA Approvals, Drugs, Companies Report | DelveInsight
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...